Quanterix Corporation (QTRX)

Market Cap	596.27M
Revenue (ttm)	122.37M
Net Income (ttm)	-32.33M
Shares Out	38.25M
EPS (ttm)	-0.86
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	278,986
Open	15.66
Previous Close	16.04
Day's Range	15.42 - 16.12
52-Week Range	11.60 - 29.70
Beta	1.33
Analysts	Strong Buy
Price Target	32.67 (+109.56%)
Earnings Date	May 7, 2024

About QTRX

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Dec 7, 2017
• Employees: 441
• Stock Exchange: NASDAQ
• Ticker Symbol: QTRX

Financial Performance

In 2023, Quanterix's revenue was $122.37 million, an increase of 15.96% compared to the previous year's $105.52 million. Losses were -$32.33 million, -66.56% less than in 2022.

Analyst Forecast

According to 3 analysts, the average rating for QTRX stock is "Strong Buy." The 12-month stock price forecast is $32.67, which is an increase of 109.56% from the latest price.

Price Target

$32.67

(109.56% upside)

Analyst Consensus: Strong Buy